BCBA/NVSD (BCBA/NVSD)

Buenos Aires Stock Exchange: BCBA/NVSD · USD

$39.6

-1.92 (-4.6%)· Recorded snapshot

Market cap	454.6T
Revenue (ttm)	87.5T
Net income (ttm)	15.3T
EPS (ttm)	$2,024
P/E (trailing)	30.1x
P/E (forward)	16.0x
Dividend	$1,073 (1.76%)
Volume	43

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 87.5T
Net income (ttm): 15.3T
EPS (ttm): $2,024
P/E (trailing): 30.1x
P/E (forward): 16.0x
Market cap: 454.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16

P25 n/aP50 n/aP75 n/a

Trailing P/E30.1

P25 n/aP50 n/aP75 n/a

ROE24.3

P25 n/aP50 n/aP75 n/a

ROIC19.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All BCBA/NVSD indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Switzerland
Country code	AR
Earnings date	2026-10-27
Employees	75,267
Employees change	-616
Employees growth	-0.81%
Enterprise value	$516.2T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-10-10
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT112521
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Market cap	$454.6T
Next earnings date	2027-02-03
Price	$39.58
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-23
Symbol	bcba/NVSD
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.87x
Average P/E ratio (3Y)	17.62x
Average P/E ratio (5Y)	17.8x
Earnings yield	3.32%
EV/Earnings	33.54x
EV/EBIT	21.33x
EV/EBITDA	16.5x
EV/FCF	21.49x
EV/Sales	5.78x
FCF / EV yield	4.65%
FCF yield	5.29%
Forward P/E	16x
Graham number	12.31012
Graham upside	-68.9%
Lynch fair value	$6.71
Lynch upside	-83.06%
P/(FCF - SBC) ratio	20.39x
P/(OCF - SBC) ratio	18.29x
P/B ratio	7.88x
P/E ratio	30.08x
P/FCF ratio	18.91x
P/OCF ratio	17.09x
P/S ratio	5.16x
Price/EBITDA ratio	12.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.98%
EBITDA margin	41.94%
Effective tax rate	20.8%
FCF margin	27.06%
Gross margin	75.21%
Operating margin	33.98%
Pretax margin	22.04%
Profit margin	17.49%
Profit per employee	$203.2M
Profitable quarters	106
Profitable years	28
Revenue per employee	$1.2B
ROA	10.86%
ROA (5Y)	7.4%
ROCE	23.04%
ROE	24.33%
ROE (5Y)	23.91%
ROIC	19.26%
ROIC (5Y)	17.5%
SBC / revenue	1.98%
Tax / revenue	4.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-28.3%
EPS growth (Q)	-68.81%
EPS growth (QoQ)	-63.16%
EPS growth 10Y	6.32%
EPS growth 3Y	12.03%
EPS growth 5Y	3.87%
EPS growth years	1
FCF growth	-20.02%
FCF growth (Q)	-17.79%
FCF growth (QoQ)	-8.09%
FCF growth 3Y	1.3%
FCF growth 5Y	2.63%
Gross profit growth	0.39%
Gross profit growth (Q)	5.89%
Gross profit growth 3Y	8.64%
Gross profit growth 5Y	3.12%
Net income growth	-30.31%
Net income growth (Q)	-69.4%
Net income growth (QoQ)	-63.17%
Net income growth 3Y	8.58%
Net income growth 5Y	0.45%
Net income growth years	1
OCF growth	-17.79%
OCF growth (Q)	-16.25%
OCF growth (QoQ)	-6.44%
OCF growth 10Y	3.71%
OCF growth 3Y	2.64%
OCF growth 5Y	2.66%
Operating income growth	-0.53%
Operating income growth (Q)	16.25%
Operating income growth 3Y	19.41%
Operating income growth 5Y	7.48%
Revenue growth	1.76%
Revenue growth (Q)	4.67%
Revenue growth (QoQ)	0.52%
Revenue growth 10Y	1.46%
Revenue growth 3Y	7.75%
Revenue growth 5Y	1.83%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.5T
Depreciation and amortization	$7T
EBIT	$29.7T
EBITDA	$36.7T
EPS	$2,024.19
Financing cash flow	$1.2T
Free cash flow	$23.9T
Free cash flow minus SBC	$22.1T
Gross profit	$65.8T
Income taxes	$4T
Investing cash flow	$-28.5T
Net borrowing	$24.9T
Net cash flow	$-1T
Net income	$15.3T
Operating cash flow minus SBC	$24.7T
Operating income	$29.7T
Revenue	$87.5T
Stock-based compensation	$1.7T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$30,058.39
Debt / EBITDA	1.98
Debt / equity	1.29
Debt / FCF	3.09
Goodwill	$41.8T
Interest coverage	12.36
Long-term assets	$134.4T
Long-term liabilities	$71.3T
Net cash (debt)	$-60.1T
Net cash / market cap	-13.32%
Net debt / EBITDA	1.64
Net debt / equity	1.05
Net debt / FCF	2.52
Piotroski F-Score	5
Property, plant and equipment	$18.9T
Shareholders' equity	$57.3T
Tangible book value	$-45.4T
Tangible book value per share	$-24,039.93
Total assets	$178.6T
Total cash	$13.5T
Total debt	$73.7T
Total liabilities	$121.4T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	$44.2T
Current liabilities	$50T
Current ratio	0.88
Inventory turnover	2.27
Net working capital	$-4.2T
Quick ratio	0.58
Working capital	$-5.8T
Working capital turnover	-23,080.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.73%
Dividend growth	20.27%
Dividend growth (3Y)	8.71%
Dividend growth years	2
Dividend payment date	2026-03-16
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	$1,072.71
Dividend yield	1.76%
Ex-dividend date	2026-03-11
Last dividend	$0.71
Payout ratio	90.4%
Shareholder yield	4.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$37.43
1D price change	-4.63%
1M price change	8.14%
1M total return	8.14%
1W price change	0.05%
1W total return	0.05%
1Y price change	16.41%
1Y return CAGR	18.4%
1Y total return	18.39%
20-day SMA	$37.76
3M price change	-2.92%
3M total return	-2.92%
50-day SMA	$39.01
52-week high	$43.00
52-week high date	2026-02-27
52-week low	$31.50
52-week low date	2025-10-29
6M price change	1.28%
6M total return	1.28%
All-time high	$43.00
All-time high date	2026-02-27
All-time low	$19.45
All-time low date	2022-10-05
Average true range (ATR)	$0.89
Average volume	38.7
Change from 52-week high	-7.95%
Change from 52-week low	25.65%
Change from all-time high	-7.95%
Change from all-time low	103.5%
Change from open	-0.03%
Day's gap	-4.6%
Dollar volume	$1,702
High price	$39.59
Low price	$39.42
Monthly RSI	63.24
Open price	$39.59
Position in 52-week range	94.12%
Previous close	$41.50
Price vs 150-day SMA	5.74%
Price vs 20-day SMA	4.82%
Price vs 50-day SMA	1.45%
Relative volume	1.11
RSI	55.45
Sharpe ratio	1.65
Sortino ratio	2.82
Volume	43
Weekly RSI	56.8
YTD price change	12.7%
YTD total return	14.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.9B
Shares change (QoQ)	-0.47%
Shares change (YoY)	-2.73%
Shares held by insiders	0.11%
Shares held by institutions	36.05%

Deeper analysis on BCBA/NVSD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BCBA/NVSD report

Is a complete BCBA/NVSD research report available?

No complete published report is available for bcba/NVSD (BCBA/NVSD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

454.6T

Revenue (ttm)

87.5T

Net income (ttm)

15.3T

EPS (ttm)

$2,024

P/E (trailing)

30.1x

P/E (forward)

16.0x

Dividend

$1,073 (1.76%)

Volume

Metric

Value

Amount currency

ARS

Country

Switzerland

Country code

Earnings date

2026-10-27

Employees

75,267

Employees change

-616

Employees growth

-0.81%

Enterprise value

$516.2T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-10-10

Fiscal year end

December

Founded

1996

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARDEUT112521

Last earnings date

2026-10-27

Last refreshed

2026-10-28

Market cap

$454.6T

Next earnings date

2027-02-03

Price

$39.58

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-23

Symbol

bcba/NVSD

Website

https://www.novartis.com

Metric

Value

Average P/E ratio (10Y)

19.87x

Average P/E ratio (3Y)

17.62x

Average P/E ratio (5Y)

17.8x

Earnings yield

3.32%

EV/Earnings

33.54x

EV/EBIT

21.33x

EV/EBITDA

16.5x

EV/FCF

21.49x

EV/Sales

5.78x

FCF / EV yield

4.65%

FCF yield

5.29%

Forward P/E

16x

Graham number

12.31012

Graham upside

-68.9%

Lynch fair value

$6.71

Lynch upside

-83.06%

P/(FCF - SBC) ratio

20.39x

P/(OCF - SBC) ratio

18.29x

P/B ratio

7.88x

P/E ratio

30.08x

P/FCF ratio

18.91x

P/OCF ratio

17.09x

P/S ratio

5.16x

Price/EBITDA ratio

12.31x

Metric

Value

EBIT margin

33.98%

EBITDA margin

41.94%

Effective tax rate

20.8%

FCF margin

27.06%

Gross margin

75.21%

Operating margin

33.98%

Pretax margin

22.04%

Profit margin

17.49%

Profit per employee

$203.2M

Profitable quarters

106

Profitable years

Revenue per employee

$1.2B

ROA

10.86%

ROA (5Y)

7.4%

ROCE

23.04%

ROE

24.33%

ROE (5Y)

23.91%

ROIC

19.26%

ROIC (5Y)

17.5%

SBC / revenue

1.98%

Tax / revenue

4.58%

Metric

Value

EPS growth

-28.3%

EPS growth (Q)

-68.81%

EPS growth (QoQ)

-63.16%

EPS growth 10Y

6.32%

EPS growth 3Y

12.03%

EPS growth 5Y

3.87%

EPS growth years

FCF growth

-20.02%

FCF growth (Q)

-17.79%

FCF growth (QoQ)

-8.09%

FCF growth 3Y

1.3%

FCF growth 5Y

2.63%

Gross profit growth

0.39%

Gross profit growth (Q)

5.89%

Gross profit growth 3Y

8.64%

Gross profit growth 5Y

3.12%

Net income growth

-30.31%

Net income growth (Q)

-69.4%

Net income growth (QoQ)

-63.17%

Net income growth 3Y

8.58%

Net income growth 5Y

0.45%

Net income growth years

OCF growth

-17.79%

OCF growth (Q)

-16.25%

OCF growth (QoQ)

-6.44%

OCF growth 10Y

3.71%

OCF growth 3Y

2.64%

OCF growth 5Y

2.66%

Operating income growth

-0.53%

Operating income growth (Q)

16.25%

Operating income growth 3Y

19.41%

Operating income growth 5Y

7.48%

Revenue growth

1.76%

Revenue growth (Q)

4.67%

Revenue growth (QoQ)

0.52%

Revenue growth 10Y

1.46%

Revenue growth 3Y

7.75%

Revenue growth 5Y

1.83%

Revenue growth years

Metric

Value

Capital expenditures

$-2.5T

Depreciation and amortization

$7T

EBIT

$29.7T

EBITDA

$36.7T

EPS

$2,024.19

Financing cash flow

$1.2T

Free cash flow

$23.9T

Free cash flow minus SBC

$22.1T

Gross profit

$65.8T

Income taxes

$4T

Investing cash flow

$-28.5T

Net borrowing

$24.9T

Net cash flow

$-1T

Net income

$15.3T

Operating cash flow minus SBC

$24.7T

Operating income

$29.7T

Revenue

$87.5T

Stock-based compensation

$1.7T

Metric

Value

Book value per share

$30,058.39

Debt / EBITDA

1.98

Debt / equity

1.29

Debt / FCF

3.09

Goodwill

$41.8T

Interest coverage

12.36

Long-term assets

$134.4T

Long-term liabilities

$71.3T

Net cash (debt)

$-60.1T

Net cash / market cap

-13.32%

Net debt / EBITDA

1.64

Net debt / equity

1.05

Net debt / FCF

2.52

Piotroski F-Score

Property, plant and equipment

$18.9T

Shareholders' equity

$57.3T

Tangible book value

$-45.4T

Tangible book value per share

$-24,039.93

Total assets

$178.6T

Total cash

$13.5T

Total debt

$73.7T

Total liabilities

$121.4T

Metric

Value

Asset turnover

0.51

Current assets

$44.2T

Current liabilities

$50T

Current ratio

0.88

Inventory turnover

2.27

Net working capital

$-4.2T

Quick ratio

0.58

Working capital

$-5.8T

Working capital turnover

-23,080.31

Metric

Value

Buyback yield / dilution

2.73%

Dividend growth

20.27%

Dividend growth (3Y)

8.71%

Dividend growth years

Dividend payment date

2026-03-16

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

$1,072.71

Dividend yield

1.76%

Ex-dividend date

2026-03-11

Last dividend

$0.71

Payout ratio

90.4%

Shareholder yield

4.49%

Metric

Value

150-day SMA

$37.43

1D price change

-4.63%

1M price change

8.14%

1M total return

8.14%

1W price change

0.05%

1W total return

0.05%

1Y price change

16.41%

1Y return CAGR

18.4%

1Y total return

18.39%

20-day SMA

$37.76

3M price change

-2.92%

3M total return

-2.92%

50-day SMA

$39.01

52-week high

$43.00

52-week high date

2026-02-27

52-week low

$31.50

52-week low date

2025-10-29

6M price change

1.28%

6M total return

1.28%

All-time high

$43.00

All-time high date

2026-02-27

All-time low

$19.45

All-time low date

2022-10-05

Average true range (ATR)

$0.89

Average volume

38.7

Change from 52-week high

-7.95%

Change from 52-week low

25.65%

Change from all-time high

-7.95%

Change from all-time low

103.5%

Change from open

-0.03%

Day's gap

-4.6%

Dollar volume

$1,702

High price

$39.59

Low price

$39.42

Monthly RSI

63.24

Open price

$39.59

Position in 52-week range

94.12%

Previous close

$41.50

Price vs 150-day SMA

5.74%

Price vs 20-day SMA

4.82%

Price vs 50-day SMA

1.45%

Relative volume

1.11

RSI

55.45

Sharpe ratio

1.65

Sortino ratio

2.82

Volume

Weekly RSI

56.8

YTD price change

12.7%

YTD total return

14.61%

Metric

Value

Float

1.9B

Shares change (QoQ)

-0.47%

Shares change (YoY)

-2.73%

Shares held by insiders

0.11%

Shares held by institutions

36.05%

BCBA/NVSD (BCBA/NVSD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/NVSD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/NVSD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/NVSD

Frequently asked questions

BCBA/NVSD (BCBA/NVSD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/NVSD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/NVSD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/NVSD

Frequently asked questions